Sunday, January 13, 2013

• JPMorgan Healthcare Conference Rewind: Rigel Pharmaceuticalsat Motley Fool (Sun, Jan 13)

Monday, January 7, 2013

• 3 Health Care Companies I'm Watching Todayat Motley Fool (Mon, Jan 7)

Thursday, January 3, 2013

• Snag RIGL 31.5% Lower Than Its Secondary?at Forbes (Thu, Jan 3)
• Why Rigel Pharmaceuticals Lost Big in Decemberat Motley Fool (Thu, Jan 3)

Friday, December 28, 2012

• Molecular Diagnostic Based Therapies Create Defensive Fiscal Cliff Resistant Biotech Portfolio StrategyWall Street Transcript (Fri, Dec 28)

Friday, December 21, 2012

• 3 Stocks to Get on Your Watchlistat Motley Fool (Fri, Dec 21)

Wednesday, December 19, 2012

• Rigel Recovers On 2013 Hope For Its Rheumatoid Arthritis Drugat Seeking Alpha (Wed, Dec 19)

Monday, December 17, 2012

• This Week in Biotechat Motley Fool (Mon, Dec 17)

Friday, December 14, 2012

• 3 Horrendous Health-Care Stocks This Weekat Motley Fool (Fri, Dec 14)
• AstraZeneca's RA Drug DisappointsZacks (Fri, Dec 14)
• Danaher Target Raised Following Investors Day and 4 Stock Analyses Attracting Attentionat Wall St. Cheat Sheet (Fri, Dec 14)
• Are these Biotech Stocks a Buy After Thursday's News?at Motley Fool (Fri, Dec 14)
• Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha (Fri, Dec 14)
• Rigel Pharmaceuticals price target lowered to $10 from $15 at Oppenheimertheflyonthewall.com (Fri, Dec 14)
• Why This Pharma Stock Tanked Yesterdayat Motley Fool (Fri, Dec 14)
• AstraZeneca rheumatoid arthritis drug disappointsat bizjournals.com (Fri, Dec 14)

Thursday, December 13, 2012

• Rigel dips on weak rheumatoid arthritis drug trial resultsat bizjournals.com (Thu, Dec 13)
• Good, Not Great, Isn't Good Enoughat Motley Fool (Thu, Dec 13)
• RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Dec 13)
• AstraZeneca’s Arthritis Drug Fails to Top Standard Therapyat Bloomberg (Thu, Dec 13)
• Stocks Near Lows In Late Trading; Drug Stocks Sinkat Investor's Business Daily (Thu, Dec 13)
• Why Rigel Pharmaceuticals Shares Got Crushedat Motley Fool (Thu, Dec 13)
• AstraZeneca falls as RA drug underperforms HumiraAP (Thu, Dec 13)
• The Occultation Of Rigel Pharmaceuticalsat Seeking Alpha (Thu, Dec 13)
• AstraZeneca falls on disappointing drug studyAP (Thu, Dec 13)

Add RIGL News to My Yahoo!